Author： Sofroniadou Sofia Goldsmith David
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.34, Iss.2, 2011-02, pp. : 97-115
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. :
Access to resources
Recommend
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. :
Inhibitors of the mammalian target of rapamycin
Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. :
mTOR pathway inhibitors in cancer therapy: moving past rapamycin
Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. :